Others AB-836 Chemical Structure CAS No. : 2445597-31-7 聽聽聽聽 AB-836聽(AB836) Catalog No.:聽URK-V2344聽Only Used For Lab. AB-836 is an orally active HBV capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein 聽 Biological Activity AB-836 is an orally active聽HBV聽capsid inhibitor. AB-836 inhibits viral replication by interacting with HBV core protein 聽 Physicochemical Properties M.Wt400.35 FormulaC20H15F3N4O2 CAS No.2445597-31-7 StorageSolide Powder -20 掳C 3years; 4掳C 2yearsIn Solvent -80掳C 6 Months -20掳C 1 Months Solubility10 mM in DMSO Chemical Name 聽 References Elisabetta Degasperi, et al. Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies. Viruses 2022, 14(11), 2404. 聽 URK-V2343_COA URK-V2343_SDS URK-V2343_TDS 聽 Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use! 聽Others website:http://www.ureiko-chem.com/inhibitors-agonists/others/
Popular posts
India Jute Bags Market Surges Due to Increasing Demand for Biodegradable Packaging
How to Choose the Top UK Immigration Lawyer for a Family Visa
Discover Hong Kong: A Family-Friendly Adventure
Rise in Demand for Natural Products and in Construction Propels Bamboo Market Growth
Bahrain: An Enchanting Family-Friendly Destination
Global Fabric Protection Market Global Trends, Share, Industry Size, Growth, Opportunities
Precision Fermentatio Market Size Is Expected To Reach USD 25.54 Billion By 2032
Precision Fermentation Market Driven by Growing Preference for Veganism and Cultured Meat Production
How to Choose the Right Dental Devices in Riyadh for Your Needs
Hormonal Contraceptives Market Size & Share| Industry Challenges, Business Overview Report 2023 to 2030
